The objectives of the community-based Early Developmental Stages of Psychopathology (EDSP) Study are described along with a detailed account of the overall design, special design features, sample characteristics and instruments used. The EDSP employed a prospective-longitudinal design to study substance use and other mental disorders in a representative population sample of 3,021 subjects aged 14–24 years (birth cohorts 1970–1981) at ‘baseline’ – the outset of the study. Two follow-up investigations were conducted after the baseline investigation covering an overall period of 3–4 years. Special design features are the linkage with a family supplement (EDSP-FS) as well as neurobiological laboratory studies of high-risk subjects.
© 2000 S. Karger AG, Basel
Dr. Roselind Lieb
Max Planck Institute of Psychiatry
Clinical Psychology and Epidemiology Unit, Kraepelinstrasse 2
D–80804 München (Germany)
Tel. +49 89 30622 241, Fax +49 89 30622 544, E-Mail firstname.lastname@example.org
Number of Print Pages : 13
Number of Figures : 2, Number of Tables : 4, Number of References : 65
European Addiction Research (Special Topic Section: Craving and Anticraving)
Vol. 6, No. 4, Year 2000 (Cover Date: December 2000)
Journal Editor: M. Krausz, Hamburg; A. Uchtenhagen, Zurich
ISSN: 1022–6877 (print), 1421–9891 (Online)
For additional information: http://www.karger.com/journals/ear
Article / Publication Details
Published online: 12/20/2000
Issue release date: December 2000
Number of Print Pages: 13
Number of Figures: 2
Number of Tables: 4
ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)
For additional information: http://www.karger.com/EAR
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.